Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Rounds in the General Hospital

PCC
Clozapine: Its Use and Monitoring
Rounds in the General Hospital

July 30, 2024

The authors provide the latest information on clozapine use, including when your patients should receive or avoid taking it, what laboratory tests are required before and during administration, and…
Desta S. Lissanu, Chirag M. Vyas, Carol S. Lim, et al
PCC
Pharmacologic Management of TBI
Rounds in the General Hospital

July 16, 2024

Cognitive complaints, including difficulties with attention, concentration, and memory, are common in patients post-TBI; however, many medications have been studied in the treatment of cognition after TBI. Read on…
Sofia E. Matta, Christina LaCroix, Kaloyan Tanev, et al
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
Rounds in the General Hospital

July 2, 2024

If you have ever been uncertain about how to evaluate patients with a chronic psychotic illness or struggled over how best to manage treatment-resistant schizophrenia, then this case vignette…
Carol S. Lim, Abigail L. Donovan, Chirag M. Vyas, et al
PCC
Neuropsychiatric Complications of Hypervitaminosis D
Rounds in the General Hospital

June 13, 2024

A 28-year-old man presented to the emergency department with severe agitation, insomnia, weakness, constipation, and muscle jerks after nonsuicidal overdosing of vitamin D.
James K. Rustad, Adam Z. Spitz, Brandon C. Wilson, et al
PCC
Impact of Disability on Medical Care
Rounds in the General Hospital

June 6, 2024

Given that many people have disabilities, physicians should develop skills that assess the level of disability, the functional consequence of illness, and the social and physical environments of patients…
Mirza Baig, Andrew S. Chun, Ashika Bains, et al
PCC
Management of Rumination and Obsessions in Primary Care
Rounds in the General Hospital

May 30, 2024

Difficult-to-control negative repetitive thoughts can manifest as ruminations or obsessions. Appropriate early identification and intervention can positively affect the course and prevent an episode of psychiatric illness.
Sharmin Ghaznavi, Charlotte Schiewe, Theodore A. Stern

Page 70

More PCC Articles

JCP
Original Research

December 3, 2019

Prior research has identified several risk factors for prescription opioid use disorder (POUD). The authors attempted to develop a conceptual model for POUD based on an existing model for…
Carlos Blanco, Melanie M. Wall, Shang-Min Liu, et al
JCP
Patient-Centered Care for Alzheimer Disease
Academic Highlights

December 3, 2019

Learn from experts in neurology, psychiatry, neuropsychology, and primary care about working with patients and care partners to create management plans for Alzheimer’s disease that ensure safety, optimize patient…
Alireza Atri, Danielle Goldfarb, Simon Sheard, et al
JCP
Commentary

December 3, 2019

This commentary discusses the findings and implications of a recent post hoc study by Thase and colleagues on the utility of combinatorial pharmacogenomics in depression.
Joseph F. Goldberg
JCP
Educational Activity

December 3, 2019

How does tardive dyskinesia affect patients’ work and relationships? Should TD be treated even if patients lack insight into its presence? Dr Joseph McEvoy considers these questions and more…
Joseph P. McEvoy
JCP
Commentary

November 26, 2019

This commentary discusses the findings and implications of a recent study by Gründer et al and also highlights the importance of following formulas to estimate creatinine clearance, reading package…
Sheldon H. Preskorn
JCP
Commentary

November 26, 2019

This commentary discusses common decisional uncertainties surrounding antidepressant discontinuation syndrome in the clinical setting and seeks to outline a roadmap for clinicians to drive research on this important topic.
Manish Kumar Jha
JCP
Clinical and Practical Psychopharmacology

November 26, 2019

Clobazam is widely used for seizure disorders and anxiety, but its potential teratogenicity has been little discussed in the literature. In this article, Dr Andrade reviews the evidence regarding…
Chittaranjan Andrade
JCP
Original Research

November 26, 2019

Risperidone is mainly metabolized hepatically to its metabolite 9-hydroxyrisperidone (9-OH-RIS), which is excreted renally. This study examined how kidney function affects serum concentrations of risperidone and 9-OH-RIS in a…
Philipp Gründer, Marc Augustin, Michael Paulzen, et al
JCP
Commentary

November 26, 2019

In this commentary, the authors outline differing models of antidepressant withdrawal syndromes and discuss how the model a clinician uses can impact interpretation of phenomena as well as management…
Giovanni A. Fava, Fiammetta Cosci
JCP
Original Research

November 19, 2019

How does prescription opioid misuse affect people who are 50 years old and older? Are there standardized tools for assessment of misuse? What associated factors should clinicians look for…
Ty S. Schepis, Sean Esteban McCabe
JCP
Original Research

November 19, 2019

Although several suicide assessment scales have been developed, their predictive properties are seldom compared. This study assessed the predictive accuracy of 4 rating scales for outcomes of suicide attempt…
Åsa U. Lindh, Marie Dahlin, Karin Beckman, et al
JCP
Letter to the Editor

November 12, 2019

Few studies have evaluated optimal dosing of intravenous (IV) ketamine for treatment-resistant depression (TRD). This report analyzes data from previous studies of IV ketamine to assess the association between…
Balwinder Singh, William V. Bobo, Keith G. Rasmussen, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe